Clinical Data

Merck Co
Biotech

Merck's PCSK9 drug mounts injectable-like cholesterol reductions

Merck's enlicitide “could see significant uptake in the primary care setting, where injectable hesitation is high,” Leerink analysts said.
Angus Liu Nov 10, 2025 10:59am
Hurdles lined up on track for race

Cogent eyes FDA approval after clearing another ph. 3 hurdle

Nov 10, 2025 10:57am
Golfer devastated after just barely missing a putt

AnaptysBio abandons rosnilimab for UC after ph. 2 fail

Nov 10, 2025 10:05am
Image comparing healthy and degraded myelin sheath

Roche reports phase 3 multiple sclerosis wins for BTK inhibitor

Nov 10, 2025 6:26am
Blood pressure monitor next to toy heart

AstraZeneca's $1.3B bet reduced BP by 14 mmHg over 12 weeks

Nov 10, 2025 6:15am
FDA stop sign

FDA puts Tenaya heart disease gene therapy trial on hold

Nov 10, 2025 5:16am